miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 101–200 of 767
MicroRNAs in adipogenesis and as therapeutic targets for obesity
Alexander, R., Lodish, H. F., & Sun, L. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561317 · Cited by 127
mi RNA s at the interface of cellular stress and disease
Emde, A., & Hornstein, E. (2014) · The EMBO Journal · doi:10.15252/embj.201488142 · Cited by 109
“Likewise, nullification of miR-375, a miRNA highly expressed in the endocrine pancreas, exhibits mild impairments in glucose homeostasis, but these are aggravated by leptin-resistance obesity (Poy et al , 2009).”
Wang, Y., Huang, C., Chintagari, N. R., Bhaskaran, M., Weng, T., Guo, Y., Xiao, X., & Liu, L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1460 · Cited by 125
Targeting microRNAs in obesity
Xie, H., Sun, L., & Lodish, H. F. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190707 · Cited by 122
“More interestingly, increased expression of miR-375 was observed in pancreatic islets of leptin-deficient ob/ob mice, which also have increased beta-cell mass [76].”
BackgroundInfluentialThe Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
Cardoso, G. S. H. R., Corrêa, L. H., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563816 · Cited by 125
MicroRNAs and Type 2 Diabetes/Obesity
Dehwah, M. A. S., Xu, A., & Huang, Q. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.11.007 · Cited by 123
Bagge, A., Clausen, T. R., Larsen, S., Ladefoged, M., Rosenstierne, M. W., Larsen, L., Vang, O., Nielsen, J. H., & Dalgaard, L. T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.082 · Cited by 123
Tsukita, S., Yamada, T., Takahashi, K., Munakata, Y., Hosaka, S., Takahashi, H., Gao, J., Shirai, Y., Kodama, S., Asai, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.002 · Cited by 122
“It has also been reported that systemic knockout of miR-375 reduces β-cell mass in young (4-week-old) mice (Poy et al., 2009), while β-cell-specific knockout of miR-200 enhances β-cell apoptosis in obese diabetic mice (Belgardt et al., 2015).”
BackgroundControlling SIRT1 expression by microRNAs in health and metabolic disease
Lee, J., & Kemper, J. K. (2010) · Aging · doi:10.18632/aging.100184 · Cited by 111
“The roles of miR-375 in pancreatic islet functions, especially in insulin gene transcription, insulin secretion, and islet cell growth, are also well established [31, 32].”
BackgroundInsm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β‐cell function
Jia, S., Ivanov, A., Blasevic, D., Müller, T., Purfürst, B., Sun, W., Chen, W., Poy, M. N., Rajewsky, N., & Birchmeier, C. (2015) · The EMBO Journal · doi:10.15252/embj.201490819 · Cited by 120
“After centrifugation, supernatants were collected, and insulin concentration was determined by ELISA (Mouse High Range Insulin ELISA, Alpco, USA).”
InfluentialSelf-citationOverexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
Hudson, J. B., Duncavage, E. J., Tamburrino, A., Salerno, P., Xi, L., Raffeld, M. A., Moley, J. F., & Chernock, R. D. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.05.001 · Cited by 113
“SLC16a2 was chosen because it was the top predicted target of miR-375 (targetscan.org) with a known role in the transport of thyroid hormone (Kinne et al., 2011; Poy et al., 2009).”
Alvarez, M. L., & DiStefano, J. K. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.010 · Cited by 116
Lyu, X., Wang, J., Guo, X., Wu, G., Yang, J., Faleti, O. D., Liu, P., Liu, T., Long, Y., Chong, T., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007484 · Cited by 115
“In recent studies, multiple cellular miRNAs, such as miR-199a-5p[10], miR-143 [11–15], miR-451 [16], miR-210 [17], miR-29b [18], miR-195-5p [19], miR-375 [20,21] have been reported to participate in the energy metabolism process by regulating the gene expression of metabolic-associated genes through posttranscriptiona…”
BackgroundPrice, N. L., Singh, A. K., Rotllan, N., Goedeke, L., Wing, A., Canfrán-Duque, A., Diaz-Ruiz, A., Araldi, E., Baldán, Á., Camporez, J.-P., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.074 · Cited by 110
“…miR-93, miR-130b, miR-143/145, miR146b, and miR-375 can have a major impact on the development of obesity and metabolic dysfunction (Ahn et al., 2013; Cioffi et al., 2015; Frost and Olson, 2011; Horie et al., 2013; Jordan et al., 2011; Pan et al., 2015; Poy et al., 2009; Price et al., 2016).”
Pancreas-enriched miRNA refines endocrine cell differentiation
Kredo‐Russo, S., Mandelbaum, A. D., Ness, A., Alon, I., Lennox, K. A., Behlke, M. A., & Hornstein, E. (2012) · Development · doi:10.1242/dev.080127 · Cited by 114
“Notably, miR375, another pancreatic miRNA (Poy et al., 2004; Avnit-Sagi et al., 2009; Poy et al., 2009), was also downregulated in Ngn3-null pancreata, yet some residual expression was maintained, unlike miR-7.”
BackgroundPillman, K. A., Phillips, C. A., Roslan, S., Toubia, J., Dredge, B. K., Bert, A. G., Lumb, R., Neumann, D. P., Li, X., Conn, S. J., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899016 · Cited by 106
“…suppressed by a second miRNA, miR-375, which is known to be enriched in certain epithelial cells and can maintain epithelial features (Ward et al , 2013; Selth et al , 2017), but also plays prominent roles in regulating pancreatic cell function and endocrine signalling (Poy et al , 2004, 2009).”
RNA-Binding Protein HuD Controls Insulin Translation
Lee, E. K., Kim, W., Tominaga, K., Martindale, J. L., Yang, X., Subaran, S. S., Carlson, O. D., Mercken, E. M., Kulkarni, R. N., Akamatsu, W., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.016 · Cited by 108
“Interestingly, miR-375 regulates insulin secretion in pancreatic b cells, and miR-375 knockout (375KO) mice have a significantly reduced pancreatic b cell mass compared with WT mice (Poy et al., 2009).”
Filios, S. R., Xu, G., Chen, J., Hong, K.-H., Gu, J., & Shalev, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592360 · Cited by 108
Eliasson, L. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.043 · Cited by 107
“The islets and other miR-375 expressing tissues are fully ablated of miR-375 in the miR-375KO (Poy et al., 2009), and the Tg375 overexpress miR-375 1.5 times specifically in the beta cells (Latreille et al., 2015).”
Influentialβ-Cell MicroRNAs: Small but Powerful
Filios, S. R., & Shalev, A. (2015) · Diabetes · doi:10.2337/db15-0831 · Cited by 106
“, miR-375 [30], miR-7 [70], miR-124a [50], miR-24 [71], let-7a [72], miR-26a [73], miR-184 [19], miR-195, miR-15, and miR-16 [74]) (Table 2).”
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
de Lucia, C., Komici, K., Borghetti, G., Femminella, G. D., Bencivenga, L., Cannavò, A., Corbi, G., Ferrara, N., Houser, S. R., Koch, W. J., et al. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00074 · Cited by 114
“Bioinformatic analysis has also shown that miR-375 regulates genes involved in cellular growth and proliferation (228).”
BackgroundFunction of microRNA‐375 and microRNA‐124a in pancreas and brain
Baroukh, N. N., & Van Obberghen, E. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07353.x · Cited by 105
Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
Saeedi Borujeni, M. J., Esfandiary, E., Taheripak, G., Codoñer‐Franch, P., Alonso‐Iglesias, E., & Mirzaei, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26271 · Cited by 106
Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects
Bolmeson, C., Esguerra, J. L. S., Salehi, A. A., Speidel, D., Eliasson, L., & Cilio, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.024 · Cited by 111
Life and death of β cells in Type 1 diabetes: A comprehensive review
Wilcox, N. S., Rui, J., Hebrok, M., & Herold, K. C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.001 · Cited by 101
Fordham, J. B., Naqvi, A. R., & Nares, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a1014-519rr · Cited by 101
MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells
Li, Q., Zhou, L., Yang, F., Wang, G., Zheng, H., Wang, D., He, Y., & Dou, K. (2012) · Tumor Biology · doi:10.1007/s13277-012-0396-1 · Cited by 104
A MicroRNA Guide for Clinicians and Basic Scientists: Background and Experimental Techniques
Bernardo, B. C., Charchar, F. J., Lin, R. C. Y., & McMullen, J. R. (2011) · Heart Lung and Circulation · doi:10.1016/j.hlc.2011.11.002 · Cited by 115
Regulation of cancer metastasis by cell-free miRNAs
Alečković, M., & Kang, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.005 · Cited by 110
Jain, D., Jain, R., Eberhard, D., Eglinger, J., Bugliani, M., Piemonti, L., Marchetti, P., & Lammert, E. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs025 · Cited by 100
“Age- and diet-dependent glucose intolerance and reduced b cell area in the absence of DJ-1 Glucose intolerance can be a consequence of b cell dysfunction and/or reduced b cell area (Ueki et al., 2006; Poy et al., 2009; Sachdeva et al., 2009; Liew et al., 2010; Esterhazy et al., 2011).”
BackgroundBleck, B., Grünig, G., Chiu, A., Liu, M., Gordon, T., Kazeros, A., & Reibman, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201165 · Cited by 106
Pullen, T. J., Sylow, L., Sun, G., Halestrap, A. P., Richter, E. A., & Rutter, G. A. (2012) · Diabetes · doi:10.2337/db11-1531 · Cited by 106
“To address this, we increased the level of pyruvate administered to 2 g/kg, a level routinely used in pyruvate tolerance tests (24,25).”
MethodThe Profiling and Role of miRNAs in Diabetes Mellitus
Kim, M., & Zhang, X. (2019) · Journal of Diabetes and Clinical Research · doi:10.33696/diabetes.1.003 · Cited by 108
“Mtpn is actively involved in the cytoskeletal remodeling process by depolymerizing actin filaments and allowing for the fusion of insulin vesicles at the β-cell membrane [76].”
The involvement of microRNAs in Type 2 diabetes
Ferland-McCollough, D., Ozanne, S. E., Siddle, K., Willis, A. E., & Bushell, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381565 · Cited by 107
Zhao, H., Guan, J. Z., Lee, H.-M., Sui, Y., He, L., Siu, J. J., Tse, P. P. P., Tong, P. C. Y., Lai, F. M., & Chan, J. C. N. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181d12613 · Cited by 111
“Recently, animal experiments demonstrated that miR-375 maintained normal pancreatic >-cell and A-cell masses.(9) In the present study, we used postmortem human pancreas tissues to examine correlations of miR-375with islet amyloid and cellular damage in type 2 diabetes.”
BackgroundInfluentialGrieco, F. A., Sebastiani, G., Juan-Mateu, J., Villate, O., Marroqui, L., Ladrière, L., Tugay, K., Regazzi, R., Bugliani, M., Marchetti, P., et al. (2017) · Diabetes · doi:10.2337/db16-0592 · Cited by 100
MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications
Regazzi, R. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1420168 · Cited by 103
Supale, S., Thorel, F., Merkwirth, C., Gjinovci, A., Herrera, P. L., Scorrano, L., Meda, P., Langer, T., & Maechler, P. (2013) · Diabetes · doi:10.2337/db13-0152 · Cited by 94
miRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells
Lahmy, R., Soleimani, M., Sanati, M. H., Behmanesh, M., Kouhkan, F., & Mobarra, N. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3054-4 · Cited by 93
MicroRNA-24/MODY Gene Regulatory Pathway Mediates Pancreatic β-Cell Dysfunction
Zhu, Y., You, W., Wang, H., Li, Y., Qiao, N., Shi, Y., Zhang, C., Bleich, D., & Han, X. (2013) · Diabetes · doi:10.2337/db13-0151 · Cited by 100
“Previously, miR-375 was found to play a significant role in endocrine pancreatic growth, development, and insulin secretion, whereby miR-375 knockout mice developed hyperglycemia with reduced b-cell mass and excess glucagon production (35).”
BackgroundRole of miRNAs in the pathogenesis and susceptibility of diabetes mellitus
Hashimoto, N., & Tanaka, T. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.150 · Cited by 99
The emerging role of micro RNA s in cardiovascular disease
Mäegdefessel, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12298 · Cited by 103
Wei, R., Yang, J., Liu, G., Gao, M., Hou, W., Zhang, L., Gao, H., Liu, Y., Chen, G., & Hong, T. (2013) · Gene · doi:10.1016/j.gene.2013.01.038 · Cited by 95
Emerging roles of non‐coding RNAs in pancreatic β‐cell function and dysfunction
Guay, C., Jacovetti, C., Nesca, V., Motterle, A., Tugay, K., & Regazzi, R. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01654.x · Cited by 92
Epigenetic regulation of microRNA‐375 and its role in melanoma development in humans
Mazar, J., DeBlasio, D., Govindarajan, S. S., Zhang, S., & Perera, R. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.025 · Cited by 89
Modepalli, V., Kumar, A., Hinds, L. A., Sharp, J. A., Nicholas, K. R., & Lefèvre, C. M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1012 · Cited by 91
“Mice mir-375 knockouts exhibit a decrease in the number of β-cells and an increase of α-cells, leading to hyperglycaemia [73].”
Sebastiani, G., Nigi, L., Grieco, G. E., Mancarella, F., Ventriglia, G., & Dotta, F. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0611-4 · Cited by 94
The miRNA Interactome in Metabolic Homeostasis
Hartig, S. M., Hamilton, M. P., Bader, D. A., & McGuire, S. E. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.006 · Cited by 95
Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer
Hui, A. B., Bruce, J. P., Alajez, N. M., Shi, W., Yue, S., Perez‐Ordoñez, B., Xu, W., O’Sullivan, B., Waldron, J. N., Cummings, B., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2102 · Cited by 93
Borujeni, M. J. S., Esfandiary, E., Baradaran, A., Valiani, A., Ghanadian, M., Codoñer‐Franch, P., Basirat, R., Alonso‐Iglesias, E., Mirzaei, H., & Yazdani, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27755 · Cited by 91
“Poy et al. (2009) in another study reported that miR‐375 is a necessary regulator for α and β cells turnover, energy homeostasis and modifying PBCs expansion in response to increasing insulin request in IR condition.”
BackgroundMicroRNAs as pharmacological targets in diabetes
Mao, Y., Mohan, R., Zhang, S., & Tang, X. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.005 · Cited by 91
miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
Shen, Y., Wang, P., Li, Y., Ye, F., Wang, F., Wan, X., Cheng, X., Lü, W., & Xie, X. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.308 · Cited by 87
“A role for miR-375 has initially been demonstrated in pancreatic development (Poy et al, 2009).”
BackgroundGene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate
Ortega, Á., Berná, G., Rojas, A., Martín, F., & Soria, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061188 · Cited by 96
Epigenetic and Disease Targets by Polyphenols
Pan, M., Lai, C., Wu, J.-C., & Ho, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319340010 · Cited by 91
MicroRNAs as regulators of beta‐cell function and dysfunction
Osmai, M., Osmai, Y., Bang‐Berthelsen, C. H., Pallesen, E. M. H., Vestergaard, A. L., Novotny, G. W., Pociot, F., & Mandrup-Poulsen, T. R. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2719 · Cited by 89
Marchand, L., Jalabert, A., Meugnier, E., Hende, K. V. D., Fabien, N., Nicolino, M. P., Madec, A., Thivolet, C. H., & Rome, S. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1869082 · Cited by 85
Kumar, A., Ren, Y., Sundaram, K., Mu, J., Sriwastva, M. K., Dryden, G. W., Lei, C., Zhang, L., Yan, J., Zhang, X., et al. (2021) · Theranostics · doi:10.7150/thno.52558 · Cited by 88
miRNAs link metabolic reprogramming to oncogenesis
Hatziapostolou, M., Polytarchou, C., & Iliopoulos, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.002 · Cited by 90
MicroRNAs and Cardiovascular Diseases
Nishiguchi, T., Imanishi, T., & Akasaka, T. (2015) · BioMed Research International · doi:10.1155/2015/682857 · Cited by 89
LaConti, J. J., Shivapurkar, N., Preet, A., Mays, A. D., Peran, I., Kim, S. E., Marshall, J. L., Riegel, A. T., & Wellstein, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020687 · Cited by 89
Qiu, C., Chen, G., & Cui, Q. (2012) · Scientific Reports · doi:10.1038/srep00318 · Cited by 84
Notch Signaling in Pancreatic Development
Li, X., Zhai, W., & Teng, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010048 · Cited by 96
“miR-375 is required for normal pancreatic genesis and maintains α- and β-cell mass [58].”
BackgroundLi, Y., Xu, X., Liang, Y., Liu, S., Xiao, H., Li, F., Cheng, H., & Zu-zhi, F. (2010) · PubMed · Cited by 88
Samandari, N., Mirza, A. H., Nielsen, L. B., Kaur, S., Hougaard, P., Fredheim, S., Mortensen, H. B., & Pociot, F. (2016) · Diabetologia · doi:10.1007/s00125-016-4156-4 · Cited by 86
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
Crigna, A. T., Samec, M., Koklesová, L., Líšková, A., Giordano, F. A., Kubatka, P., & Golubnitschaja, O. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00226-x · Cited by 81
Beta Cell 5′-Shifted isomiRs Are Candidate Regulatory Hubs in Type 2 Diabetes
Baran-Gale, J., Fannin, E. E., Kurtz, C. L., & Sethupathy, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073240 · Cited by 82
Role of non‐coding RNA s in pancreatic beta‐cell development and physiology
Eliasson, L., & Esguerra, J. L. S. (2014) · Acta Physiologica · doi:10.1111/apha.12285 · Cited by 83
“Deletion of miR-375 [375KO; (Poy et al. 2009)] resulted in severe imbalance of alpha- and beta-cells, in which the combined increase in alpha-cells and reduction in beta-cells lead to abnormal glucose homeostasis in the animals.”
BackgroundPeripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes
Al‐Kafaji, G., Al-Mahroos, G., Al-Sayed, N., Hasan, Z. A., Nawaz, S., & Bakhiet, M. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4416 · Cited by 84
Sangiao‐Alvarellos, S., Pena-Bello, L., Manfredi-Lozano, M., Tena‐Sempere, M., & Cordido, F. (2014) · Endocrinology · doi:10.1210/en.2013-1770 · Cited by 94
Zhu, Y., Jiang, Q., Lou, X., Ji, X., Wen, Z., Wu, J., Tao, H., Jiang, T., He, W., Wang, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035147 · Cited by 80
MicroRNAs in Autoimmune Diseases
Qu, Z., Li, W., & Fu, B. (2014) · BioMed Research International · doi:10.1155/2014/527895 · Cited by 87
Dumortier, O., Hinault, C., Gautier, N., Patouraux, S., Casamento, V., & Van Obberghen, E. (2014) · Diabetes · doi:10.2337/db13-1431 · Cited by 78
The potential roles of exosomes in pancreatic cancer initiation and metastasis
Sun, W., Ren, Y., Lu, Z., & Zhao, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01255-w · Cited by 81
Antisense miR-7 Impairs Insulin Expression in Developing Pancreas and in Cultured Pancreatic Buds
Nieto, M., Hevia, P., Garcia, E. J., Klein, D., Álvarez-Cubela, S., Bravo-Egaña, V., Rosero, S., Molano, R. D., Vargas, N., Ricordi, C., et al. (2012) · Cell Transplantation · doi:10.3727/096368911x612521 · Cited by 82
Zhang, N., Lin, J.-K., Chen, J., Liu, X., Liu, J.-L., Luo, H., Li, Y., & Cui, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.425504 · Cited by 80
MicroRNAs -the Next Generation Therapeutic Targets in Human Diseases
Sakthivel, S., Selvan, S. T., Archunan, G., Gulyás, B. Z., & Padmanabhan, P. (2013) · Theranostics · doi:10.7150/thno.7026 · Cited by 79
Hennessy, E., CLYNES, M. M., Jeppesen, P. B., & O’Driscoll, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.116 · Cited by 83
Hu, A., Huang, J., Xu, W., Jin, X., Li, J., Tang, Y., Huang, X., Cui, H., & Sun, G.-B. (2014) · Europe PMC (PubMed Central) · Cited by 79
DICER Inactivation Identifies Pancreatic β-Cell “Disallowed” Genes Targeted by MicroRNAs
Martínez-Sánchez, A., Nguyen‐Tu, M., & Rutter, G. A. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1059 · Cited by 73
miRNA, Development and Disease
Amiel, J., de Pontual, L., & Henrion‐Caude, A. (2012) · Advances in genetics · doi:10.1016/b978-0-12-404742-6.00001-6 · Cited by 79
Calatayud, D., Dehlendorff, C., Boisen, M. K., Hasselby, J. P., Schultz, N. A., Werner, J., Immervoll, H., Molven, A., Hansen, C. P., & Johansen, J. S. (2017) · Biomarker Research · doi:10.1186/s40364-017-0087-6 · Cited by 79
“miR-375 plays a role in the development and maintenance of the α- and β-cell mass in the normal pancreas and is upregulated in patients with type 2 diabetes [75, 76].”
BackgroundFarr, R. J., Januszewski, A. S., Joglekar, M. V., Liang, H. H., McAuley, A. K., Hewitt, A. W., Thomas, H. E., Loudovaris, T., Kay, T. W. H., Jenkins, A. J., et al. (2015) · Scientific Reports · doi:10.1038/srep10375 · Cited by 75
Role and therapeutic potential of microRNAs in diabetes
Kolfschoten, I., Roggli, E., Nesca, V., & Regazzi, R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01118.x · Cited by 79
Galimov, A., Merry, T. L., Luca, E., Rushing, E. J., Mizbani, A., Turcekova, K., Hartung, A., Croce, C. M., Ristow, M., & Krützfeldt, J. (2016) · Stem Cells · doi:10.1002/stem.2281 · Cited by 76
Epigenetics and Cellular Metabolism
Xu, W., Wang, F., Yu, Z., & Xin, F. (2016) · Genetics & Epigenetics · doi:10.4137/geg.s32160 · Cited by 75
miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes
Zheng, Y., Wang, Z., & Zhou, Z. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.7 · Cited by 74
Al-Muhtaresh, H. A., & Al‐Kafaji, G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020012 · Cited by 73
“[22,33] have demonstrated that miR-375 is abundantly expressed in the pancreatic β–cells and essential for maintaining normal pancreatic cell mass.”
BackgroundKaur, P., Kotru, S., Singh, S., Behera, B. S., & Munshi, A. (2020) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00760-2 · Cited by 76
Wu, J., Ji, X., Zhu, L., Jiang, Q., Wen, Z., Xu, S. H., Shao, W., Cai, J., Du, Q., Zhu, Y., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.038 · Cited by 78
Giricz, O., Reynolds, P. A., Ramnauth, A., Liu, C., Wang, T., Stead, L. A., Childs, G. J., Rohan, T. E., Shapiro, N., Fineberg, S., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2978 · Cited by 70
mRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects
Martínez-Pacheco, M., Hidalgo‐Miranda, A., Romero-Cordoba, S. L., Valverde, M., & Rojas, E. (2013) · Gene · doi:10.1016/j.gene.2013.09.049 · Cited by 71
MiR-375 Promotes Redifferentiation of Adult Human β Cells Expanded In Vitro
Nathan, G., Kredo‐Russo, S., Geiger, T., Lenz, A., Kaspi, H., Hornstein, E., & Efrat, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122108 · Cited by 74
Rafacho, A., Gonçalves-Neto, L. M., Santos-Silva, J. C., Alonso-Magdalena, P., Merino, B., Taboga, S. R., Carneiro, E. M., Boschero, A. C., Nadal, A., & Quesada, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093531 · Cited by 67
MicroRNAs in diabetes and diabetes-associated complications
Lorenzen, J. M., Kumarswamy, R., Dangwal, S., & Thum, T. (2012) · RNA Biology · doi:10.4161/rna.20162 · Cited by 75
miR-200s Contribute to Interleukin-6 (IL-6)-induced Insulin Resistance in Hepatocytes
Dou, L., Zhao, T., Wang, L., Huang, X., Jiao, J., Gao, D., Zhang, H., Shen, T., Man, Y., Wang, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423145 · Cited by 67
MicroRNAs: a new ray of hope for diabetes mellitus
Kumar, M., Nath, S., Prasad, H. K., Sharma, G., & Li, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2055-0 · Cited by 74
“Among these is miR-375, which was first cloned from a mouse insulinoma pancreatic β-cell line (MIN6 cells) and identified as the most abundant, evolutionarily conserved, islet-specific miRNA (Poy et al., 2004) .”
BackgroundInfluentialExpression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus
Sun, K., Chang, X., YIN, L., Li, J., Zhou, T., Zhang, C., & Chen, X. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1872 · Cited by 71
“High levels of miR-375 are found in the pancreatic islet of obese (ob/ob) mice and have been shown to regulate glucose homeostasis (8).”
BackgroundNohata, N., Hanazawa, T., Kinoshita, T., Okamoto, Y., & Seki, N. (2012) · Auris Nasus Larynx · doi:10.1016/j.anl.2012.07.001 · Cited by 71
Outside the coding genome, mammalian microRNAs confer structural and functional complexity
Olive, V., Minella, A. C., & He, L. (2015) · Science Signaling · doi:10.1126/scisignal.2005813 · Cited by 66
mi RNA s, polyphenols, and chronic disease
Bladé, C., Baselga‐Escudero, L., Salvadó, M. J., & Arola‐Arnal, A. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200454 · Cited by 73
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.